• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of p53 product in Chinese human bladder carcinoma.

作者信息

Ye D W, Zheng J F, Qian S X, Ma Y J

机构信息

Department of Urology, Changhai Hospital, People's Republic of China.

出版信息

Urol Res. 1993 May;21(3):223-6. doi: 10.1007/BF00590040.

DOI:10.1007/BF00590040
PMID:7688167
Abstract

Expression of p53 protein was examined in 67 cases of primary transitional cell carcinoma of the bladder and 6 normal controls using an immunohistochemical method on paraffin sections. Positive nuclear staining for p53 in malignant cells was found in 34 (51%) of the 67 cancer patients; no positive staining for p53 was detected in any of the normal controls or in the benign cells, including stromal and inflammatory cells, within the tumor tissue. There were 8 positive cases (33%) in 24 grade G1 tumors, 12 (48%) in 25 G2 tumors and 14 (78%) in 18 G3 tumors. p53 protein was detected positively in 14 (36%) of 39 superficial tumors (Tis-T1) and in 20 (71%) of 28 invasive tumors (T2-T4). Thus, positive staining for p53 was found more frequently in poorly differentiated tumors (chi-squared test: G3/G1 + G2 P < 0.01) and in invasive tumors (chi-squared test: T2-T4/Tis-T1 P < 0.01). Expression of p53 was also closely associated with recurrence of tumors. Alterations in p53 expression may be of prognostic value in cases of bladder transitional cell carcinoma.

摘要

相似文献

1
Expression of p53 product in Chinese human bladder carcinoma.
Urol Res. 1993 May;21(3):223-6. doi: 10.1007/BF00590040.
2
Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.细胞周期蛋白D1在膀胱移行细胞癌中的表达:与p53、waf1、pRb和Ki67的相关性
Br J Cancer. 2001 Jan;84(2):270-5. doi: 10.1054/bjoc.2000.1557.
3
Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors.石蜡切片上免疫组化标志物(PCNA、Ki-67、486p和p53)的表达及其与浅表性膀胱肿瘤复发率的关系。
Urol Int. 1997;59(2):88-94. doi: 10.1159/000283032.
4
P53 expression in small cell carcinoma of the urinary bladder: biological and prognostic implications.p53在膀胱小细胞癌中的表达:生物学及预后意义
Anticancer Res. 2005 May-Jun;25(3B):2001-4.
5
Detection of P53 tumor-suppressor-gene protein in bladder tumors and prostate cancer: possible clinical implications.膀胱肿瘤和前列腺癌中P53肿瘤抑制基因蛋白的检测:可能的临床意义。
World J Urol. 1994;12(6):345-51. doi: 10.1007/BF00184117.
6
[Expression of mutant P53 gene protein product in human bladder carcinoma].
Zhonghua Wai Ke Za Zhi. 1993 Aug;31(8):484-6.
7
Prognostic Value of p53 Expression Intensity in Urothelial Cancers.p53表达强度在尿路上皮癌中的预后价值
J Coll Physicians Surg Pak. 2017 Apr;27(4):232-236.
8
Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.p53肿瘤抑制蛋白在浅表性和浸润性移行细胞膀胱癌中的过表达评估:与DNA倍体的比较
Urology. 1995 Sep;46(3):334-40. doi: 10.1016/S0090-4295(99)80216-7.
9
Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.评估P53蛋白过表达、Ki67增殖活性和有丝分裂指数作为膀胱浅表性移行细胞癌肿瘤复发标志物的情况。
Eur Urol. 2000 Sep;38(3):287-96. doi: 10.1159/000020295.
10
Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: correlation with Ki67 index.视网膜母细胞瘤基因产物和p53蛋白在膀胱癌中的表达:与Ki67指数的相关性。
Br J Urol. 1995 Feb;75(2):173-9. doi: 10.1111/j.1464-410x.1995.tb07306.x.

引用本文的文献

1
Spotlight on differentially expressed genes in urinary bladder cancer.聚焦膀胱癌中差异表达的基因。
PLoS One. 2011 Apr 5;6(4):e18255. doi: 10.1371/journal.pone.0018255.
2
The relation of mutant p53 accumulation in transitional cell carcinoma of bladder with pathological stage, grade, recurrence and survival.膀胱移行细胞癌中突变型p53蓄积与病理分期、分级、复发及生存的关系。
Int Urol Nephrol. 2001;33(3):473-8. doi: 10.1023/a:1019559121580.

本文引用的文献

1
Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.编码p53肿瘤抗原的基因与ras在细胞转化中的协同作用。
Nature. 1984;312(5995):649-51. doi: 10.1038/312649a0.
2
Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies.通过显微注射单克隆抗体研究p53蛋白在细胞增殖中的作用。
Mol Cell Biol. 1984 Feb;4(2):276-81. doi: 10.1128/mcb.4.2.276-281.1984.
3
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.Ha-ras癌基因在人类泌尿系统肿瘤中因体细胞改变而被激活。
Nature. 1984;309(5967):464-6. doi: 10.1038/309464a0.
4
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.
5
Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells.正常细胞和转化细胞中54K细胞肿瘤抗原的翻译后调控
Mol Cell Biol. 1981 Feb;1(2):101-10. doi: 10.1128/mcb.1.2.101-110.1981.
6
Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes.人外周血淋巴细胞细胞周期中p53蛋白的表达
Exp Cell Res. 1985 Sep;160(1):31-46. doi: 10.1016/0014-4827(85)90233-2.
7
Meth A fibrosarcoma cells express two transforming mutant p53 species.
Oncogene. 1988 Sep;3(3):313-21.
8
c-myc oncoprotein levels in bladder cancer.膀胱癌中c-myc癌蛋白水平
Urol Res. 1988;16(5):341-4. doi: 10.1007/BF00256039.
9
Allele loss on short arm of chromosome 17 in breast cancers.乳腺癌中17号染色体短臂上的等位基因缺失。
Lancet. 1988 Dec 17;2(8625):1384-5. doi: 10.1016/s0140-6736(88)90584-3.
10
Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.小细胞肺癌中3号、13号和17号染色体以及肺腺癌中3号染色体的杂合性缺失。
Proc Natl Acad Sci U S A. 1987 Dec;84(24):9252-6. doi: 10.1073/pnas.84.24.9252.